Retrospective study on the incidence and outcome of Adenovirus infections in patients who undergo haploidentical SCT Diseases Group Infectious Diseases Working Party (IDWP) Principal investigator Maura Faraci
Outcome of allogeneic stem cell transplantation in patients with psychiatric disorders Diseases Group Transplant Complications Working Party (TCWP) Principal investigator Zinaida Peric
Outcome of patients with Intermediate risk Acute Myelogenous Leukemia in first remission and no detectable residual disease (MRD negative) transplanted with a haploidentical donor versus autografted Group Acute Leukemia Working Party (ALWP) Type of transplant Principal investigator Norbert-Claude GORIN
Comparison of outcomes after unrelated double-unit cord blood and haploidentical peripheral blood stem cell transplantation in adults with acute myeloid leukemia, a study on behalf of Eurocord and ALWP-EBMT Group Acute Leukemia Working Party (ALWP) Principal investigator Annalisa Ruggeri
The role of measurable residual disease (MRD) at the time of allogeneic stem cell transplantation in patients with AML in CR transplanted from unrelated donors with Post transplant cyclophosphamide Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
PTCY MMUD vs Haplo in active disease for AML Group Acute Leukemia Working Party (ALWP) Principal investigator Frédéric Baron
Graft Engineering for allogeneic hematopoietic stem cell transplantation (HSCT) and modified donor lymphocyte infusion (DLI) Diseases Group Cellular Therapy & Immunobiology Working Party (CTIWP) Type of transplant Principal investigator Moniek de Witte
Trends in non sibling donor in HSCT CR2 Diseases Group Acute Leukemia Working Party (ALWP) Principal investigator Mohamad Mohty
Trends in donor characteristics for unrelated Stem Cell Transplantation in patients with acute myeloid leukemia Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
Haploidentical versus matched sibling donors hematopoietic stem cell transplantation for adult patients with relapsed/refractory acute lymphoblastic leukemia Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
Trends in allogeneic stem cell transplantation (HSCT) over two decades in patients with secondary acute myelogenous leukemia (sAML) being transplanted from sibling (MSD) or unrelated donors (UD). A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) Principal investigator Arnon Nagler
A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. A Study of the EBMT Chronic Malignancies Working Party Group Chronic Malignancies Working Party (CMWP) Principal investigator Meral Beksac